Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Yatabe

Showing results (91-100 of 129) with videos related to

Pageof 13
Sort By:
Journal of Medicine|January 1, 1987
A hitherto unreported case of 21-hydroxylase deficiency associated with Bartter's syndrome and a balanced 6-9 translocationR Yabe, K Mizuno, M Ojima, et al.
The Journal of Biological Chemistry|September 19, 2015
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)Cristian Follmer, Eduardo Coelho-Cerqueira, Danilo Y Yatabe-Franco, et al.
Histopathology|June 25, 1998
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformationT Yokoi, T Tsuzuki, Y Yatabe, et al.
The American Journal of Surgical Pathology|September 1, 1996
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entityY Yatabe, S Nakamura, M Seto, et al.
Endoscopy|May 25, 2012
First report of a mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)T Ogura, M Tajika, S Hijioka, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2018
Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary SiteH Hasegawa, M Ando, Y Yatabe, et al.
British Journal of Cancer|November 8, 2006
Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasisH Yokoyama, Y Ikehara, Y Kodera, et al.
Endoscopy|December 2, 2010
Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasmsY Sawai, K Yamao, V Bhatia, et al.
British Journal of Cancer|February 3, 2011
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerT Yokota, T Ura, N Shibata, et al.
International Journal of Hematology|September 25, 1999
Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two casesY Kagami, R Sobue, N Ito, et al.
Pageof 13

Showing results (91-100 of 129) with videos related to

Sort By:
Pageof 13
Journal of Medicine|January 1, 1987
A hitherto unreported case of 21-hydroxylase deficiency associated with Bartter's syndrome and a balanced 6-9 translocationR Yabe, K Mizuno, M Ojima, et al.
The Journal of Biological Chemistry|September 19, 2015
Oligomerization and Membrane-binding Properties of Covalent Adducts Formed by the Interaction of α-Synuclein with the Toxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde (DOPAL)Cristian Follmer, Eduardo Coelho-Cerqueira, Danilo Y Yatabe-Franco, et al.
Histopathology|June 25, 1998
Solitary fibrous tumour: significance of p53 and CD34 immunoreactivity in its malignant transformationT Yokoi, T Tsuzuki, Y Yatabe, et al.
The American Journal of Surgical Pathology|September 1, 1996
Clinicopathologic study of PRAD1/cyclin D1 overexpressing lymphoma with special reference to mantle cell lymphoma. A distinct molecular pathologic entityY Yatabe, S Nakamura, M Seto, et al.
Endoscopy|May 25, 2012
First report of a mucosa-associated lymphoid tissue (MALT) lymphoma of the esophagus diagnosed by endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA)T Ogura, M Tajika, S Hijioka, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 11, 2018
Site-specific Chemotherapy Based on Predicted Primary Site by Pathological Profile for Carcinoma of Unknown Primary SiteH Hasegawa, M Ando, Y Yatabe, et al.
British Journal of Cancer|November 8, 2006
Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasisH Yokoyama, Y Ikehara, Y Kodera, et al.
Endoscopy|December 2, 2010
Development of pancreatic cancers during long-term follow-up of side-branch intraductal papillary mucinous neoplasmsY Sawai, K Yamao, V Bhatia, et al.
British Journal of Cancer|February 3, 2011
BRAF mutation is a powerful prognostic factor in advanced and recurrent colorectal cancerT Yokota, T Ura, N Shibata, et al.
International Journal of Hematology|September 25, 1999
Cytotoxic large T-cell lymphoma with fulminant clinical course, CD8+ and CD56- phenotype, and its relation to Epstein-Barr virus: a report of two casesY Kagami, R Sobue, N Ito, et al.
Pageof 13